Citadel Advisors’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.28M | Sell |
1,708,134
-164,494
| -9% | -$701K | ﹤0.01% | 1598 |
|
|
2025
Q1 | $7.04M | Buy |
1,872,628
+189,421
| +11% | +$712K | ﹤0.01% | 1501 |
|
|
2024
Q4 | $9.81M | Buy |
1,683,207
+430,462
| +34% | +$2.51M | ﹤0.01% | 1336 |
|
|
2024
Q3 | $15M | Buy |
1,252,745
+1,120,492
| +847% | +$13.4M | ﹤0.01% | 1021 |
|
|
2024
Q2 | $1.43M | Sell |
132,253
-648,407
| -83% | -$7.02M | ﹤0.01% | 2730 |
|
|
2024
Q1 | $8.84M | Buy |
780,660
+496,708
| +175% | +$5.62M | ﹤0.01% | 1363 |
|
|
2023
Q4 | $3.98M | Sell |
283,952
-154,952
| -35% | -$2.17M | ﹤0.01% | 1806 |
|
|
2023
Q3 | $5.42M | Sell |
438,904
-197,571
| -31% | -$2.44M | ﹤0.01% | 1560 |
|
|
2023
Q2 | $5.75M | Sell |
636,475
-594,041
| -48% | -$5.36M | ﹤0.01% | 1605 |
|
|
2023
Q1 | $4.27M | Buy |
1,230,516
+5,366
| +0.4% | +$18.6K | ﹤0.01% | 1943 |
|
|
2022
Q4 | $3M | Sell |
1,225,150
-27,792
| -2% | -$68.1K | ﹤0.01% | 2224 |
|
|
2022
Q3 | $3.46M | Sell |
1,252,942
-228,273
| -15% | -$630K | ﹤0.01% | 2200 |
|
|
2022
Q2 | $6.03M | Buy |
1,481,215
+219,550
| +17% | +$893K | ﹤0.01% | 1691 |
|
|
2022
Q1 | $5.37M | Sell |
1,261,665
-164,847
| -12% | -$702K | ﹤0.01% | 2011 |
|
|
2021
Q4 | $13.4M | Sell |
1,426,512
-50,543
| -3% | -$473K | ﹤0.01% | 1217 |
|
|
2021
Q3 | $40.7M | Buy |
1,477,055
+40,576
| +3% | +$1.12M | 0.01% | 540 |
|
|
2021
Q2 | $40.2M | Buy |
1,436,479
+1,683
| +0.1% | +$47.1K | 0.01% | 590 |
|
|
2021
Q1 | $47.6M | Hold |
1,434,796
| – | – | 0.01% | 493 |
|
|
2020
Q4 | $69M | Buy |
+1,434,796
| New | +$69M | 0.02% | 321 |
|